CN109276631A - 一种护眼药膏 - Google Patents
一种护眼药膏 Download PDFInfo
- Publication number
- CN109276631A CN109276631A CN201811315575.7A CN201811315575A CN109276631A CN 109276631 A CN109276631 A CN 109276631A CN 201811315575 A CN201811315575 A CN 201811315575A CN 109276631 A CN109276631 A CN 109276631A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- powder
- eyeshield
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000843 powder Substances 0.000 claims abstract description 28
- 229920002472 Starch Polymers 0.000 claims abstract description 15
- 235000019698 starch Nutrition 0.000 claims abstract description 15
- 239000008107 starch Substances 0.000 claims abstract description 15
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 14
- 241001116389 Aloe Species 0.000 claims abstract description 14
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 14
- 241000241413 Propolis Species 0.000 claims abstract description 14
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 14
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 14
- 229940041616 menthol Drugs 0.000 claims abstract description 14
- 239000010445 mica Substances 0.000 claims abstract description 14
- 229910052618 mica group Inorganic materials 0.000 claims abstract description 14
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 14
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940069949 propolis Drugs 0.000 claims abstract description 14
- 239000008117 stearic acid Substances 0.000 claims abstract description 14
- 241001165494 Rhodiola Species 0.000 claims abstract description 13
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 13
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004327 boric acid Substances 0.000 claims abstract description 13
- 235000012680 lutein Nutrition 0.000 claims abstract description 13
- 229960005375 lutein Drugs 0.000 claims abstract description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 13
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 13
- 239000001656 lutein Substances 0.000 claims abstract description 13
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 13
- 229940099259 vaseline Drugs 0.000 claims abstract description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 13
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- -1 vaseline Substances 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 14
- 241001065361 Gynostemma Species 0.000 claims description 13
- 239000010433 feldspar Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000008155 medical solution Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- 229910052796 boron Inorganic materials 0.000 claims 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 1
- 208000003464 asthenopia Diseases 0.000 abstract description 8
- 208000030533 eye disease Diseases 0.000 abstract description 5
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QQGISFDJEJMKIL-JAIQZWGSSA-N (5z)-5-[[3-(hydroxymethyl)thiophen-2-yl]methylidene]-10-methoxy-2,2,4-trimethyl-1h-chromeno[3,4-f]quinolin-9-ol Chemical group C1=CC=2NC(C)(C)C=C(C)C=2C2=C1C=1C(OC)=C(O)C=CC=1O\C2=C/C=1SC=CC=1CO QQGISFDJEJMKIL-JAIQZWGSSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000004303 plantar wart Diseases 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种护眼药膏,属于中药技术领域,该药膏的配方包括:云母、芦荟、菟丝子、赤木通、红景天、叶黄素、绞股蓝、刺五加、蜂胶、地浆、蛇胆粉、薄荷脑、琥珀、珍珠粉、凡士林、硼酸、三乙醇胺、十八/十六醇、甘油、硬脂酸。本发明的药膏可有效缓解眼部疲劳,长期使用可缓解治疗多种常见的眼部疾病。
Description
技术领域
本发明涉及中药领域,尤其涉及一种能有保护眼睛防止视觉疲劳、对多种病症有明显缓解疗效的护眼药膏。
背景技术
眼睛是感知光线的器官,也是人们识别万物的窗口,在人们的学习生活中起到重要的作用。随着社会的发展,各种科技产品尤其是电子产品的兴起,人们眼睛的负担越来越重,尤其在某些特殊行业中尤其如此。超负荷的用眼不仅会导致眼睛疲劳,长久还会导致各种眼部疾病的产生。
发明内容
针对现有技术的上述缺陷,本发明旨在提供一种可有效缓解眼部疲劳,对多种眼部病症有明显疗效的护眼药膏。
为了实现上述目的,本发明采用如下技术方案:
一种护眼药膏,该药膏的配方中包括:云母、芦荟、菟丝子、赤木通、红景天、叶黄素、绞股蓝、刺五加、蜂胶、地浆、蛇胆粉、薄荷脑、琥珀、珍珠粉、凡士林、硼酸、三乙醇胺、十八/十六醇、甘油、硬脂酸。
优选的:所述配方各组分含量的有效范围为按质量份数计:云母1~1.5份、芦荟5~15份、菟丝子3~8份、赤木通2~9份、红景天3~9份、叶黄素5~13份、绞股蓝2~5份、刺五加4~6份、蜂胶4~8份、地浆22~38份、蛇胆粉3~6份、薄荷脑2~8份、琥珀4~10份、珍珠粉3~10份、凡士林2~6份、硼酸3~6份、三乙醇胺10~13份、十八/十六醇8~15份、甘油4~8份、硬脂酸6~8份。
优选的:所述配方各组分最佳含量为按质量份数计:云母1.2份、芦荟8份、菟丝子5份、赤木通6份、红景天7份、叶黄素11份、绞股蓝3份、刺五加5份、蜂胶6份、地浆27份、蛇胆粉5份、薄荷脑4份、琥珀9份、珍珠粉6份、凡士林5份、硼酸5份、三乙醇胺11份、十八/十六醇13份、甘油7份、硬脂酸7份。
本发明还公开了所述的一种护眼药膏的制备方法,包括如下步骤:
(1):在药罐底部铺设一层3~5mm的黄土,用纱布覆盖并四周压紧,放入蜂窝状的长石制块,取相应质量份数的菟丝子、芦荟、赤木通、地浆、绞股蓝、刺五加、红景天加入总质量份数3倍的水,充分浸泡8小时,文火煎煮5小时,取出长石制块,倒出混合药液,过500目过滤网静置2小时得到滤液A;
(2):取相应质量份数的云母、蛇胆粉、薄荷脑、琥珀、珍珠粉、硼酸,用超微粉碎机粉碎研磨15分钟后过1000目过滤网得到混合粉末B;
(3):将相应质量份数的蜂胶加热熔融后,边搅拌边加入相应质量份数的叶黄素、凡士林,待温度降至78℃时,加入滤液A搅拌均匀,得到底液C;
(4):将相应质量份数的三乙醇胺、十八/十六醇、甘油、硬脂酸加热至95℃后加入混合粉末B,边加热边搅拌12分钟得到稠膏D;
(5):将底液C加热至130℃,并加入稠膏D,利用超声波搅拌器边加热边搅拌8分钟,静置冷却即可得到所述的眼药膏。
本发明中各组分的具体功效如下:
云母:除邪气,安五脏,益子精,明目。
芦荟:泻火、解毒、杀菌、抗炎、湿润美容、活血、免疫和再生、解毒、抗衰老、镇痛、镇静、防晒。
菟丝子:甘、温,归肾、肝、脾经,具有滋补肝肾、固精缩尿、安胎、明目、止泻之功效,始载《神农本草经》,被列为上品;久服明目,轻身延年。
赤木通:痈肿、肿毒、酸涩、微毒。
红景天:抗缺氧、抗疲劳、抗辐射、抗病毒、延缓机体衰老。
叶黄素:抗氧化、光保护。
绞股蓝:消炎解毒、抗衰老、缓解紧张、镇静、镇痛。
刺五加:抗衰老、抗疲劳、抗菌消炎。
蜂胶:治皲裂、肼胝、跖疣、寻常疣、治恶性肿瘤和创伤、保护肉芽组织、利于伤口愈合。
地浆:解中毒烦闷、解一切鱼肉果菜药物诸菌毒。
蛇胆粉:清热解毒,化痰镇痉。
薄荷脑:清凉止痒。
琥珀:镇惊安神、散瘀止血。
珍珠粉:去死皮、美白、润滑、抗衰老。
凡士林:保湿、隔离皮肤、防止感染。
硼酸:抑菌。
三乙醇胺:乳化、保湿、增稠。
十八/十六醇:润滑、乳化、增黏。
甘油:配剂外用软膏。
硬脂酸:乳化作用。
本发明与现有技术相比,提供了一种可以保护眼睛,防止眼干、眼涩、眼胀,对多种病症有明显缓解疗效的护眼药膏。本药膏以中药为原料,采用熬煮、碾碎、物理及超声波搅拌的工艺相结合,并在制备过程中加入了临时辅助配方(长石、黄土),在保证药物疗效的同时去除部分药物毒性,具有显著的医疗保健效果。
具体实施方式
实施例1
一种护眼药膏,所述配方各组分含量为按质量份数计:云母1份、芦荟5份、菟丝子3份、赤木通2份、红景天3份、叶黄素5份、绞股蓝2份、刺五加4份、蜂胶4份、地浆22份、蛇胆粉3份、薄荷脑2份、琥珀4份、珍珠粉3份、凡士林2份、硼酸3份、三乙醇胺10份、十八/十六醇8份、甘油4份、硬脂酸6份。
另外,本发明还提供了该药膏的制备方法,具体包括以下步骤:
(1):在药罐底部铺设一层3~5mm的黄土,用纱布覆盖并四周压紧,放入蜂窝状的长石制块,取相应质量份数的菟丝子、芦荟、赤木通、地浆、绞股蓝、刺五加、红景天加入总质量份数3倍的水,充分浸泡8小时,文火煎煮5小时,取出长石制块,倒出混合药液,过500目过滤网静置2小时得到滤液A;
(2):取相应质量份数的云母、蛇胆粉、薄荷脑、琥珀、珍珠粉、硼酸,用超微粉碎机粉碎研磨15分钟后过1000目过滤网得到混合粉末B;
(3):将相应质量份数的蜂胶加热熔融后,边搅拌边加入相应质量份数的叶黄素、凡士林,待温度降至78℃时,加入滤液A搅拌均匀,得到底液C;
(4):将相应质量份数的三乙醇胺、十八/十六醇、甘油、硬脂酸加热至95℃后加入混合粉末B,边加热边搅拌12分钟得到稠膏D;
(5):将底液C加热至130℃,并加入稠膏D,利用超声波搅拌器边加热边搅拌8分钟,静置冷却即可得到所述的眼药膏。
本发明制备方法的步骤(1)中的长石制块对药性的提高有着重要的作用。《神农本草经》有记载:长石,主身热,四肢寒厥,利小便,通血脉,明目,去翳,眇,下三虫,杀蛊毒。经多次实验得出,加入长石后得到的药膏相比未加入长石制得的药膏,药性能提高8%~13%。
在《本草纲目》有记载:入地三尺以下的黄土,勿沾污物,可作药;黄土可解诸药毒;眼睛突然看不见东西,用黄土溶水中,取上面清液洗眼。因此黄土不仅可解毒,而且在对眼睛疾病治疗上有着意想不到的效果。本发明制备方法的步骤(1)的药罐底层铺设的黄土,一方面在熬煮药的过程中,可使黄土中的药性充分渗出并融入到药液中;另一方面黄土的药性配合上述的地浆可以更加彻底的清除赤木通的毒性。经过多次试验得出,在药罐底部铺设的黄土层在3~5mm时即可达到良好的效果,相比没有铺设黄土的药罐得到的药膏药性能提高42%~53%。
本发明中的赤木通含有微毒,在常规时用作痈肿、狗咬等肿毒,紧急时可直接用作外敷。经过多次试验,在对缓解眼部疲劳和肿痛方面有着明显的疗效,相比一般的药物有着见效更快、效果显著等优点。为排除其微量的毒性,在本药膏的配方中加入了地浆。据《本草纲目》记载:地浆有解中毒烦闷,解一切鱼肉果菜药物诸菌毒的作用。本发明的地浆使用一方面可中和赤木通的毒性,消除其对人体的危害;另一方面在药膏的制配过程中充当调节剂的作用,减少外加水的用量,提高药性。
本药膏所采用的配方中有多个配方含有微量毒性,但通过上述制备工艺步骤可以将毒性充分消除,并能提高药性;最后采用的超声波搅拌可以使多种配方混合更加均匀,具有显著的进步。
该药膏的使用方法为:外用,使用时将眼部擦洗干净,取适量本品,闭上眼睛,用中指在眼部周围轻柔两分钟,每天使用1~2次。眼部不适人群使用本药膏1~2次,即可有效改善眼部疲劳状况,长期使用可缓解治疗多种眼部疾病。
实施例2
一种护眼药膏,所述配方各组分含量为按质量份数计:云母1.5份、芦荟15份、菟丝子8份、赤木通9份、红景天9份、叶黄素13份、绞股蓝5份、刺五加6份、蜂胶8份、地浆38份、蛇胆粉6份、薄荷脑8份、琥珀10份、珍珠粉10份、凡士林6份、硼酸6份、三乙醇胺13份、十八/十六醇15份、甘油8份、硬脂酸8份。
眼部不适人群使用本药膏1~2次,即可有效改善眼部疲劳状况,长期使用可缓解治疗多种眼部疾病。另外,本实施例药膏的制备方法和使用方法与实施例1相同。
实施例3
一种护眼药膏,所述配方各组分含量为按质量份数计:云母1.2份、芦荟8份、菟丝子5份、赤木通6份、红景天7份、叶黄素11份、绞股蓝3份、刺五加5份、蜂胶6份、地浆27份、蛇胆粉5份、薄荷脑4份、琥珀9份、珍珠粉6份、凡士林5份、硼酸5份、三乙醇胺11份、十八/十六醇13份、甘油7份、硬脂酸7份。
眼部不适人群使用本药膏1~2次,即可有效改善眼部疲劳状况,长期使用可缓解治疗多种眼部疾病。另外,本实施例药膏的制备方法和使用方法与实施例1相同。
上述实施例仅是本发明的优选实施例,在本发明的基础上做出的任何与本发明精神与实质相一致修改或改进都应该在本发明的保护范围之内。
Claims (4)
1.一种护眼药膏,其特征在于,该药膏的配方中包括:云母、芦荟、菟丝子、赤木通、红景天、叶黄素、绞股蓝、刺五加、蜂胶、地浆、蛇胆粉、薄荷脑、琥珀、珍珠粉、凡士林、硼酸、三乙醇胺、十八/十六醇、甘油、硬脂酸。
2.如权利要求1所述的一种护眼药膏,其特征在于,所述配方各组分含量的有效范围为按质量份数计:云母1~1.5份、芦荟5~15份、菟丝子3~8份、赤木通2~9份、红景天3~9份、叶黄素5~13份、绞股蓝2~5份、刺五加4~6份、蜂胶4~8份、地浆22~38份、蛇胆粉3~6份、薄荷脑2~8份、琥珀4~10份、珍珠粉3~10份、凡士林2~6份、硼酸3~6份、三乙醇胺10~13份、十八/十六醇8~15份、甘油4~8份、硬脂酸6~8份。
3.如权利要求2所述的一种护眼药膏,其特征在于,所述配方各组分最佳含量为按质量份数计:云母1.2份、芦荟8份、菟丝子5份、赤木通6份、红景天7份、叶黄素11份、绞股蓝3份、刺五加5份、蜂胶6份、地浆27份、蛇胆粉5份、薄荷脑4份、琥珀9份、珍珠粉6份、凡士林5份、硼酸5份、三乙醇胺11份、十八/十六醇13份、甘油7份、硬脂酸7份。
4.如权利要求1至3任一项所述的一种护眼药膏的制备方法,其特征在于,包括如下步骤:
(1):在药罐底部铺设一层3~5mm的黄土,用纱布覆盖并四周压紧,放入蜂窝状的长石制块,取相应质量份数的菟丝子、芦荟、赤木通、地浆、绞股蓝、刺五加、红景天加入总质量份数3倍的水,充分浸泡8小时,文火煎煮5小时,取出长石制块,倒出混合药液,过500目过滤网静置2小时得到滤液A;
(2):取相应质量份数的云母、蛇胆粉、薄荷脑、琥珀、珍珠粉、硼酸,用超微粉碎机粉碎研磨15分钟后过1000目过滤网得到混合粉末B;
(3):将相应质量份数的蜂胶加热熔融后,边搅拌边加入相应质量份数的叶黄素、凡士林,待温度降至78℃时,加入滤液A搅拌均匀,得到底液C;
(4):将相应质量份数的三乙醇胺、十八/十六醇、甘油、硬脂酸加热至95℃后加入混合粉末B,边加热边搅拌12分钟得到稠膏D;
(5):将底液C加热至130℃,并加入稠膏D,利用超声波搅拌器边加热边搅拌8分钟,静置冷却即可得到所述的眼药膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811315575.7A CN109276631A (zh) | 2018-11-07 | 2018-11-07 | 一种护眼药膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811315575.7A CN109276631A (zh) | 2018-11-07 | 2018-11-07 | 一种护眼药膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109276631A true CN109276631A (zh) | 2019-01-29 |
Family
ID=65174945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811315575.7A Pending CN109276631A (zh) | 2018-11-07 | 2018-11-07 | 一种护眼药膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109276631A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109820931A (zh) * | 2019-03-18 | 2019-05-31 | 河南聚明亮视力药业有限公司 | 一种眼保健膏及其制备方法 |
-
2018
- 2018-11-07 CN CN201811315575.7A patent/CN109276631A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109820931A (zh) * | 2019-03-18 | 2019-05-31 | 河南聚明亮视力药业有限公司 | 一种眼保健膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105395467A (zh) | 一种中药组合物、美肤化妆品及其应用 | |
CN102846993A (zh) | 小儿高热惊厥外用膏药 | |
CN106474444A (zh) | 一种外用中药药包配方、药包及其使用方法 | |
CN109276631A (zh) | 一种护眼药膏 | |
CN102274380B (zh) | 治疗烧、烫伤的外用药 | |
CN101317873B (zh) | 骨质增生祛痛膏及其制备方法 | |
CN103463580A (zh) | 治疗经筋、骨、关节疼痛的中药膏及其制备方法 | |
CN107137471A (zh) | 一种止痛中药组合物及其制备方法和应用 | |
CN102716304A (zh) | 一种治疗皮肤病的中药制剂及其制备方法 | |
CN111035610A (zh) | 一种含茶青素的减肥乳及其制备方法 | |
WO2015125963A1 (ja) | 天然鉱石粉末入りセラピー用オイル | |
CN101284045B (zh) | 高效皮肤洗剂及其制备方法 | |
CN101780193A (zh) | 一种治疗骨折、各种伤口不愈合的特效膏药 | |
CN101507804B (zh) | 一种伤痛药及其制备工艺 | |
CN109288948A (zh) | 一种缓解视疲劳的眼药膏 | |
CN105663370A (zh) | 一种治疗跖疣的外用药剂 | |
CN105055755A (zh) | 一种治疗腰椎间盘突出症的外用中药膏药 | |
CN104623040A (zh) | 一种用于创口杀菌消炎的护理组合物及其制备方法 | |
CN103893422B (zh) | 修复皮肤损伤的药物及其制备方法 | |
CN108653631A (zh) | 一种涂抹式膏药及其制备方法 | |
CN109893561A (zh) | 一种治疗烧烫伤的中药组合物及其制备方法 | |
CN100522133C (zh) | 生物美容祛斑露及其生产方法 | |
RU2282458C1 (ru) | Способ лечения заболеваний костно-мышечной системы на основе композиции "изумрудная" | |
CN1256115C (zh) | 治疗风寒性膝关节疼痛的外用膏药 | |
CN110123923A (zh) | 一种药膏及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190129 |